FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131842728> ?p ?o ?g. }

• W3131842728 abstract "Abstract Inflammatory bowel disease (IBD) has emerged a global disease and the ascending incidence and prevalence is accompanied by elevated morbidity, mortality, and substantial healthcare system costs. However, the current typical one‐size‐fits‐all therapeutic approach is suboptimal for a substantial proportion of patients due to the variability in the course of IBD and a considerable number of patients do not have positive response to the clinically approved drugs, so there is still a great, unmet demand for novel alternative therapeutic approaches. Spleen tyrosine kinase (Syk), a cytoplasmic nonreceptor protein tyrosine kinase, plays crucial roles in signal transduction and there are emerging data implicating that Syk participates in pathogenesis of several gut disorders, such as IBD. In this study, we observed the Syk expression in IBD patients and explored the effects of therapeutic Syk inhibition using small‐molecule Syk inhibitor piceatannol in bone marrow–derived macrophages (BMDMs). In addition, due to the poor bioavailability and pharmacokinetics of small‐molecule tyrosine kinase inhibitors and superiority of targeting nanoparticles‐based drug delivery system, we herein prepared piceatannol‐encapsulated poly(lactic‐co‐glycolic acid) nanoparticles that conjugated with chemokine C–C motif ligand 4 (P‐NPs‐C) and studied its therapeutic effects in vitro in BMDMs and in vivo in experimental colitis model. Our results indicated that in addition to alleviating colitis, oral administration of P‐NPs‐C promoted the restoration of intestinal barrier function and improved intestinal microflora dysbiosis, which represents a promising treatment for IBD." @default.
• W3131842728 created "2021-03-01" @default.
• W3131842728 creator A5000240387 @default.
• W3131842728 creator A5001666372 @default.
• W3131842728 creator A5005994901 @default.
• W3131842728 creator A5009543963 @default.
• W3131842728 creator A5010692383 @default.
• W3131842728 creator A5013614593 @default.
• W3131842728 creator A5013754783 @default.
• W3131842728 creator A5037567740 @default.
• W3131842728 creator A5048718447 @default.
• W3131842728 creator A5077444654 @default.
• W3131842728 creator A5089632045 @default.
• W3131842728 creator A5091066303 @default.
• W3131842728 creator A5091699610 @default.
• W3131842728 date "2021-02-01" @default.
• W3131842728 modified "2023-10-14" @default.
• W3131842728 title "CCL4‐mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease" @default.
• W3131842728 cites W1964465182 @default.
• W3131842728 cites W1994420770 @default.
• W3131842728 cites W2003110090 @default.
• W3131842728 cites W2017341404 @default.
• W3131842728 cites W2053386771 @default.
• W3131842728 cites W2066826113 @default.
• W3131842728 cites W2087032263 @default.
• W3131842728 cites W2112981618 @default.
• W3131842728 cites W2181256014 @default.
• W3131842728 cites W2326555481 @default.
• W3131842728 cites W2338281459 @default.
• W3131842728 cites W2423259930 @default.
• W3131842728 cites W2516695653 @default.
• W3131842728 cites W2583464358 @default.
• W3131842728 cites W2583730344 @default.
• W3131842728 cites W2606862276 @default.
• W3131842728 cites W2736839127 @default.
• W3131842728 cites W2740226484 @default.
• W3131842728 cites W2740303420 @default.
• W3131842728 cites W2746297999 @default.
• W3131842728 cites W2749425110 @default.
• W3131842728 cites W2765680011 @default.
• W3131842728 cites W2765774007 @default.
• W3131842728 cites W2766046358 @default.
• W3131842728 cites W2772423028 @default.
• W3131842728 cites W2777651400 @default.
• W3131842728 cites W2782405156 @default.
• W3131842728 cites W2792339500 @default.
• W3131842728 cites W2804858910 @default.
• W3131842728 cites W2806409874 @default.
• W3131842728 cites W2888061430 @default.
• W3131842728 cites W2890491535 @default.
• W3131842728 cites W2891145791 @default.
• W3131842728 cites W2902743637 @default.
• W3131842728 cites W2908547111 @default.
• W3131842728 cites W2912709864 @default.
• W3131842728 cites W2913914536 @default.
• W3131842728 cites W2914018369 @default.
• W3131842728 cites W2940782501 @default.
• W3131842728 cites W2979255852 @default.
• W3131842728 cites W3013588707 @default.
• W3131842728 cites W3015418027 @default.
• W3131842728 cites W3020563063 @default.
• W3131842728 cites W3060019369 @default.
• W3131842728 cites W3081703999 @default.
• W3131842728 cites W3094239161 @default.
• W3131842728 doi "https://doi.org/10.1002/ctm2.339" @default.
• W3131842728 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7888545" @default.
• W3131842728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33634985" @default.
• W3131842728 hasPublicationYear "2021" @default.
• W3131842728 type Work @default.
• W3131842728 sameAs 3131842728 @default.
• W3131842728 citedByCount "10" @default.
• W3131842728 countsByYear W31318427282021 @default.
• W3131842728 countsByYear W31318427282022 @default.
• W3131842728 countsByYear W31318427282023 @default.
• W3131842728 crossrefType "journal-article" @default.
• W3131842728 hasAuthorship W3131842728A5000240387 @default.
• W3131842728 hasAuthorship W3131842728A5001666372 @default.
• W3131842728 hasAuthorship W3131842728A5005994901 @default.
• W3131842728 hasAuthorship W3131842728A5009543963 @default.
• W3131842728 hasAuthorship W3131842728A5010692383 @default.
• W3131842728 hasAuthorship W3131842728A5013614593 @default.
• W3131842728 hasAuthorship W3131842728A5013754783 @default.
• W3131842728 hasAuthorship W3131842728A5037567740 @default.
• W3131842728 hasAuthorship W3131842728A5048718447 @default.
• W3131842728 hasAuthorship W3131842728A5077444654 @default.
• W3131842728 hasAuthorship W3131842728A5089632045 @default.
• W3131842728 hasAuthorship W3131842728A5091066303 @default.
• W3131842728 hasAuthorship W3131842728A5091699610 @default.
• W3131842728 hasBestOaLocation W31318427281 @default.
• W3131842728 hasConcept C126322002 @default.
• W3131842728 hasConcept C170493617 @default.
• W3131842728 hasConcept C203014093 @default.
• W3131842728 hasConcept C2775862500 @default.
• W3131842728 hasConcept C2778260677 @default.
• W3131842728 hasConcept C2779134260 @default.
• W3131842728 hasConcept C35174551 @default.
• W3131842728 hasConcept C42362537 @default.
• W3131842728 hasConcept C502942594 @default.
• W3131842728 hasConcept C71924100 @default.
• W3131842728 hasConcept C98274493 @default.

• next